Search results
Results from the WOW.Com Content Network
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
GINA conducts continuous review of scientific publications on asthma and is a leader in disseminating information about the care of patients with asthma. [2] GINA publishes resources such as evidence-based guidelines for asthma management, and runs special events such as World Asthma Day. GINA's guidelines, revised each year, are used by ...
Helen Reddel or Helen Kathryn Reddel is a respiratory physician, a professor at Macquarie University, and adjunct professor at the University of Sydney, Chair of the Global Initiative for Asthma, [1] [2] who was awarded an Order of Australia in 2024, for services to respiratory medicine. [3]
COVID-19 pandemic in Australia by state and territory. Location [a] Cases [b] Deaths Recoveries Active [c] Hospital [d] Tests Notes Ref. 12 / 12 6,635,645 7,807 6,239,947
The ACT Government ended the COVID-19 Management Declaration on 28 February 2023. At this time a requirement that people report positive rapid antigen test results was the only remaining COVID-19 health restriction; the ACT was the last jurisdiction in Australia to retain this requirement. The Garran Surge Centre was also closed at this time. [80]
This article documents the chronology and epidemiology of SARS-CoV-2, the virus which causes the coronavirus disease 2019 and is responsible for the COVID-19 pandemic in Australia during 2020. The first human case of COVID-19 in Australia was identified in Melbourne in January 2020.
The COVID-19 pandemic in Australia was a part of the worldwide pandemic of the coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first confirmed case in Australia was identified on 25 January 2020, in Victoria , when a man who had returned from Wuhan , Hubei Province, China , tested positive ...
Asthma phenotyping and endotyping has emerged as a novel approach to asthma classification inspired by precision medicine which separates the clinical presentations of asthma, or asthma phenotypes, from their underlying causes, or asthma endotypes. The best-supported endotypic distinction is the type 2-high/type 2-low distinction.